Skip to main content
All lobbying clients

Immix Biopharma, Inc.

Immix Biopharma, Inc. has been represented by 5 lobbying firms in 14 filings in 2026, with $460,000 in reported spending; the newest was posted November 4, 2026.

As filed: IMMIX BIOPHARMA, INC. Client based in California.

Biopharmaceutical company

$460,000 Reported spend
14 Filings counted
5 Outside firms hired
0 Bills named

Spend is reported income plus in-house expenses across 14 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 5 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as IMMIX BIOPHARMA INC, IMMIX BIOPHARMA INC.

 Who filed for this client 5

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 1 year
  • 2026 $460,000 14 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 8
  • SENATE 8
  • Health & Human Services, Dept of (HHS) 2
  • Agriculture, Dept of (USDA) 1
  • Food & Drug Administration (FDA) 1
  • Health Resources & Services Administration (HRSA) 1
 Recent filings 14 total
Registration
Brownstein Hyatt Farber Schreck, LLP
4th Quarter 2026 (Oct 1 - Dec 31) · posted Nov 4, 2026
View →
Q3 report
First Principles Strategies, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026
View →
Registration
First Principles Strategies, LLC
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View →
Q3 report
Tarplin, Downs & Young, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
Continental Strategy, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $105,000 income · posted Oct 20, 2026
View →
Q3 report
Axadvocacy Government Relations
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View →
Q2 report
Tarplin, Downs & Young, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 20, 2026
View →
Q2 report
Continental Strategy, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $105,000 income · posted Jul 19, 2026
View →
Q2 report
Axadvocacy Government Relations
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 17, 2026
View →
Registration
Axadvocacy Government Relations
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 7, 2026
View →
Q1 report
Tarplin, Downs & Young, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 20, 2026
View →
Registration
Tarplin, Downs & Young, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · posted Apr 20, 2026
View →
Q1 reportNo activity
Continental Strategy, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · $50,000 income · posted Apr 20, 2026
View →
Registration
Continental Strategy, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · posted Feb 19, 2026
View →

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem